Presidential Symposium 1
Invited discussant LBA1
Date
08 Oct 2016Session
Presidential Symposium 1Presenters
Stephen JohnstonAuthors
S. JohnstonAuthor affiliations
- Medical Oncology, Royal Marsden Hospital NHS Foundation Trust, London/GB
Resources
Login to access the resources on OncologyPRO.
If you do not have an ESMO account, please create one for free.
Resources from the same session
3552 - First-line ribociclib + letrozole for postmenopausal women with hormone receptor-positive (HR+), HER2-negative (HER2–), advanced breast cancer (ABC)
Presenter: Gabriel Hortobagyi
Session: Presidential Symposium 1
Resources:
Abstract
Slides
3070 - Ipilimumab (IPI) vs placebo (PBO) after complete resection of stage III melanoma: final overall survival results from the EORTC 18071 randomized, double-blind, phase 3 trial
Presenter: Alexander Eggermont
Session: Presidential Symposium 1
Resources:
Abstract
Slides
Invited discussant LBA2
Presenter: Olivier Michielin
Session: Presidential Symposium 1
Resources:
Slides
3367 - A randomized, double-blind phase 3 trial of maintenance therapy with niraparib vs placebo in patients with platinum-sensitive recurrent ovarian cancer (ENGOT-OV16/NOVA trial)
Presenter: Mansoor Raza Mirza
Session: Presidential Symposium 1
Resources:
Abstract
Slides
Invited discussant LBA3
Presenter: Sandro Pignata
Session: Presidential Symposium 1
Resources:
Slides
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
-
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.